Tilray (NASDAQ:TLRY) Stock Price Up 0.8%

Tilray Inc (NASDAQ:TLRY)’s stock price shot up 0.8% on Monday . The company traded as high as $1.87 and last traded at $1.84. 13,345,254 shares were traded during mid-day trading, a decline of 54% from the average session volume of 29,081,066 shares. The stock had previously closed at $1.82.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on TLRY. Canaccord Genuity Group decreased their target price on Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Alliance Global Partners boosted their target price on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research report on Friday, April 5th. Finally, CIBC decreased their target price on Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a research report on Wednesday, April 10th.

Tilray Stock Up 2.8 %

The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The company’s 50-day moving average price is $1.97 and its 200 day moving average price is $1.97.

Institutional Investors Weigh In On Tilray

Several hedge funds and other institutional investors have recently made changes to their positions in the business. HighPoint Advisor Group LLC purchased a new stake in shares of Tilray during the 4th quarter valued at about $43,000. Vanguard Group Inc. increased its holdings in Tilray by 7.3% in the 4th quarter. Vanguard Group Inc. now owns 3,407,269 shares of the company’s stock worth $7,837,000 after acquiring an additional 231,381 shares in the last quarter. Austin Wealth Management LLC purchased a new stake in Tilray in the 4th quarter worth approximately $115,000. Wellington Wealth Strategies LLC. purchased a new stake in Tilray in the 4th quarter worth approximately $29,000. Finally, Point72 Asset Management L.P. increased its holdings in Tilray by 35.6% in the 4th quarter. Point72 Asset Management L.P. now owns 2,362,271 shares of the company’s stock worth $5,433,000 after acquiring an additional 620,700 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.